Logo

Partek Licenses Genomics Suite Software to Israel-Based Sheba, Weizmann

May 26, 2006

NEW YORK, May 26 (GenomeWeb News) - Partek announced today that it has licensed its Partek Genomics Suite software to the Chaim Sheba Medical Center and the Weizmann Institute of Science.

The Tel Aviv, Israel-based Sheba Medical Center will use the software to statistically analyze data from its hemato-oncology studies. The Rehovot, Israel-based Weizmann Institute will use it to aid in research in a multitude of areas, including cancer, diabetes, nanoscience, and the environment.

Partek is based in St. Louis, Mo.

Breaking News
The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.